Clinical Trials Logo

Lung Diseases, Obstructive clinical trials

View clinical trials related to Lung Diseases, Obstructive.

Filter by:

NCT ID: NCT05975788 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease

Start date: November 2023
Phase: Phase 4
Study type: Interventional

This is a multi-center, prospective study. This study aims to investigate the incidence of acute exacerbation within 12 months, as well as the safety of Staphylococcus and Neisseria Tablets on patients with chronic obstructive pulmonary disease (COPD). In addition, this study investigates the improvement of hospitalization, improvement of pulmonary function, improvement of symptoms, and the use of anti-Infective drugs among COPD patients.

NCT ID: NCT05972239 Recruiting - COPD Clinical Trials

Balance Training in Chronic Obstructive Pulmonary Disease

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The aim of the study will be to verify whether the addition of an exercise program aimed to improve balance can reduce the risk of falling in subjects with COPD over 80 years of age compared to the standard rehabilitation program. Patients will be randomly assigned in two groups (intervention and control). The pulmonary rehabilitation (PR) program is organized in accordance with current guidelines.

NCT ID: NCT05967091 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Ryme Medical TLD Pilot Study

Start date: September 2023
Phase: N/A
Study type: Interventional

Targeted lung denervation (TLD) with the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD) - Ryme Medical TLD Pilot Study

NCT ID: NCT05964491 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Video Resources for People With Chronic Obstructive Pulmonary Disease: An Exploratory Qualitative Study

Start date: October 20, 2022
Phase:
Study type: Observational

The IPCRG & Teesside University have searched the internet for video self management content for people living with COPD. Resources were reviewed by healthcare professionals and developed into a digital magazine to support people living with chronic obstructive Pulmonary Disease (COPD). The aims of this study are to 1. evaluate the use of the digital magazine format with video self-management content from an end user perspective, including 1. what characteristics a good video resource should have 2. what information is important to people with COPD to include in videos and digital magazines, 3. the useability of a digital magazine format 2. Explore the opinions, experiences and preferences of people living with COPD for accessing online self-management content including barriers and facilitators for accessing online self-management video content

NCT ID: NCT05955482 Recruiting - COPD Clinical Trials

Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease

PROMISE
Start date: July 24, 2023
Phase:
Study type: Observational

This is a 12 month study of up to 500 people with COPD to determine if the NuvoAir clinical service leads to lower rates of severe COPD exacerbations, hospitalizations, emergency room visits, and total cost of care compared to a similar group that doesn't receive care from the NuvoAir clinical service.

NCT ID: NCT05952999 Enrolling by invitation - Hypertension Clinical Trials

Analysis of the Virtual Acute Care at Home Experience

HaH
Start date: August 15, 2023
Phase:
Study type: Observational

The purpose of this study is to examine the implementation, intervention effectiveness, and dissemination of a digital acute care delivery model for improving selected health outcomes in the Hospital at Home population.

NCT ID: NCT05948891 Recruiting - COPD Clinical Trials

Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study

TriNEXT
Start date: August 1, 2023
Phase:
Study type: Observational

This is an observational, prospective, multicentric, cohort study conducted in France to evaluate the QoL in COPD patients treated with TRIMBOW NEXThaler 88/5/9 in a routine clinical practice setting. Patients enrolled in this study will be patients diagnosed with a COPD with a ratio of post-bronchodilator (salbutamol 400 μg) forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) of less than 0.7 to whom TRIMBOW NEXThaler 88/5/9 has been initiated by an hospital or local pulmonologists in accordance with clinical practice and marketing authorization.

NCT ID: NCT05940480 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

TCM Daoyin Therapy in Individuals At-risk for COPD

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease. The aim of prospective randomized study is to evaluate the effects of TCM Daoyin training on Individuals at-risk for COPD.

NCT ID: NCT05939999 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects of Elastic Tape on Pulmonary Rehabilitation of Patients With Chronic Obstructive Pulmonary Disease

ETReaCOPD
Start date: October 26, 2023
Phase: N/A
Study type: Interventional

Evaluate the effect of the use of elastic tape in chest wall and abdomen in the physical capacity, psychosocial distress levels, quality of life and anxiety, and depression symptoms of individuals with moderate to very severe chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation.

NCT ID: NCT05937854 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

BETTER COPD-PH
Start date: April 1, 2024
Phase: Phase 2
Study type: Interventional

The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investigators will also assess whether tadalafil improves quality of life, home daily physical activity, exercise endurance, the frequency of acute flares of COPD, blood pressure in the lungs, and lung function. Veterans who enroll in the trial will be allocated by chance to either active tadalafil or an inactive identical capsule (placebo). Neither the Veteran nor the investigator will know whether the Veteran is taking tadalafil or placebo. Veterans will be followed closely in clinic or by telephone at 1, 2, 3, 4, 5, and 6 months, with attention to side effects and safety. At 1,3, and 6 months the investigators will repeat the questionnaires and testing of blood pressures in the lung and lung function. The investigators anticipate that the results of this study will determine whether tadalafil improves shortness of breath when added to usual medications for COPD.